Cargando…

Prevalence of RT-qPCR-detected SARS-CoV-2 infection at schools: First results from the Austrian School-SARS-CoV-2 prospective cohort study

BACKGROUND: The role of schools in the SARS-CoV-2 pandemic is much debated. We aimed to quantify reliably the prevalence of SARS-CoV-2 infections at schools detected with reverse-transcription quantitative polymerase-chain-reaction (RT-qPCR). METHODS: This nationwide prospective cohort study monitor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Willeit, Peter, Krause, Robert, Lamprecht, Bernd, Berghold, Andrea, Hanson, Buck, Stelzl, Evelyn, Stoiber, Heribert, Zuber, Johannes, Heinen, Robert, Köhler, Alwin, Bernhard, David, Borena, Wegene, Doppler, Christian, von Laer, Dorothee, Schmidt, Hannes, Pröll, Johannes, Steinmetz, Ivo, Wagner, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350968/ https://www.ncbi.nlm.nih.gov/pubmed/34396360 http://dx.doi.org/10.1016/j.lanepe.2021.100086

Ejemplares similares

Sensitivity and specificity of the antigen-based anterior nasal self-testing programme for detecting SARS-CoV-2 infection in schools, Austria, March 2021
por: Willeit, Peter, et al.
Publicado: (2021)

Comparison of Four SARS-CoV-2 Neutralization Assays
por: Riepler, Lydia, et al.
Publicado: (2020)

High SARS-CoV-2 seroprevalence in children and adults in the Austrian ski resort of Ischgl
por: Knabl, Ludwig, et al.
Publicado: (2021)

Six-Month Follow-Up of Immune Responses after a Rapid Mass Vaccination against SARS-CoV-2 with BNT162b2 in the District of Schwaz/Austria
por: Bánki, Zoltán, et al.
Publicado: (2022)

Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography
por: Rössler, Annika, et al.
Publicado: (2023)

Characterization of Immune Responses to SARS-CoV-2 and Other Human Pathogenic Coronaviruses Using a Multiplex Bead-Based Immunoassay
por: Borena, Wegene, et al.
Publicado: (2021)

High Prevalence of Undocumented SARS-CoV-2 Infections in the Pediatric Population of the Tyrolean District of Schwaz
por: Harthaller, Teresa, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 infection in the Tyrolean district of Schwaz at the time of the rapid mass vaccination in March 2021 following B.1.351-variant outbreak
por: Willeit, Peter, et al.
Publicado: (2022)

Assessing the impact of SARS-CoV-2 prevention measures in Austrian schools using agent-based simulations and cluster tracing data
por: Lasser, Jana, et al.
Publicado: (2022)

Marked Increase in Avidity of SARS-CoV-2 Antibodies 7–8 Months After Infection Is Not Diminished in Old Age
por: Pichler, Daniel, et al.
Publicado: (2021)

Estimating seroprevalence of SARS-CoV-2 antibodies using three self-reported symptoms: development of a prediction model based on data from Ischgl, Austria
por: Lehmann, Jens, et al.
Publicado: (2021)

SARS-CoV-2 rapid antigen tests provide benefits for epidemic control – observations from Austrian schools
por: Polechová, Jitka, et al.
Publicado: (2022)

12-month SARS-CoV-2 antibody persistency in a Tyrolean COVID-19 cohort
por: Deisenhammer, Florian, et al.
Publicado: (2021)

Persistence of immunity to SARS-CoV-2 over time in the ski resort Ischgl
por: Borena, Wegene, et al.
Publicado: (2021)

Prevalence of asymptomatic SARS-CoV-2 infection in an Austrian cohort
por: Mara, Elisabeth, et al.
Publicado: (2021)

The first 8 weeks of the Austrian SARS-CoV-2 epidemic
por: Nagel, Anna, et al.
Publicado: (2021)

Prevalence of SARS-CoV-2 antibodies in healthy blood donors from the state of Tyrol, Austria, in summer 2020
por: Siller, Anita, et al.
Publicado: (2021)

The role of schools and school-aged children in SARS-CoV-2 transmission
por: Flasche, Stefan, et al.
Publicado: (2021)

SARS-CoV2 infection and primary school closure
por: Vanhems, Philippe
Publicado: (2020)

Preventing the introduction of SARS-CoV-2 into school settings
por: Thampi, Nisha, et al.
Publicado: (2021)

Antibody seroprevalence and rate of asymptomatic infections with SARS-CoV-2 in Austrian hospital personnel
por: Leister, Iris, et al.
Publicado: (2021)

6-month SARS-CoV-2 antibody persistency in a Tyrolian COVID-19 cohort
por: Deisenhammer, Florian, et al.
Publicado: (2020)

Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
por: Goyal, Rajat, et al.
Publicado: (2022)

Physical distancing in schools for SARS-CoV-2 and the resurgence of rhinovirus
por: Poole, Stephen, et al.
Publicado: (2020)

Factors affecting the transmission of SARS‐CoV‐2 in school settings
por: Yuan, Haokun, et al.
Publicado: (2022)

Persisting Antibody Response to SARS-CoV-2 in a Local Austrian Population
por: Ladage, Dennis, et al.
Publicado: (2021)

Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2021)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
por: Huh, Jung Eun, et al.
Publicado: (2021)

SARS-CoV, MERS-CoV and SARS-CoV-2: A Diagnostic Challenge
por: Ezhilan, Madeshwari, et al.
Publicado: (2021)

A Review of SARS-CoV2: Compared With SARS-CoV and MERS-CoV
por: Zhou, Huan, et al.
Publicado: (2021)

Transmission Cycle of SARS-CoV and SARS-CoV-2
por: Yadav, Tushar, et al.
Publicado: (2020)

Saliva for molecular detection of SARS‐CoV‐2 in pre‐school and school‐age children
por: Delaunay‐Moisan, Agnes, et al.
Publicado: (2022)

SARS-CoV-2 Infection among School Population of One Developing Country. Do School Closures Protect Students and Teachers against SARS-CoV-2 Infection?
por: Colonia, Carol Bibiana, et al.
Publicado: (2021)

Comparison between an in-house SARS-CoV-2 ELISpot and the T-Spot® Discovery SARS-CoV-2 for the assessment of T cell responses in prior SARS-CoV-2-infected individuals
por: Mak, Willem A., et al.
Publicado: (2022)

SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development
por: de Souza Silva, Guilherme Antonio, et al.
Publicado: (2020)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
por: Abdelghany, T.M., et al.
Publicado: (2021)

Imaging findings in coronavirus infections: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Franquet, Tomas, et al.
Publicado: (2020)

Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)

Comparative susceptibility of SARS-CoV-2, SARS-CoV, and MERS-CoV across mammals
por: Li, Meng, et al.
Publicado: (2023)

Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational phase 4 trial
por: Seekircher, Lisa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0hgil6nhka2ohsruipm98sp9ag